In contrast, Allo15BCAR-NKT cells exhibited cytotoxicity against both BCMA+ and BCMA− tumor cells, indicating a less pronounced dependence on BCAR-BCMA recognition, albeit with a comparatively reduced killing capacity toward BCMA− tumor cells (Fig. 2i). The gene discussed is TNFRSF17; the disease is neoplasm.